• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未破裂颅内动脉瘤血管内治疗后的通路斑块与弥散加权病变分析:一项前瞻性研究

Pathway plaques and diffusion-weighted lesion analysis after endovascular treatment of unruptured intracranial aneurysms: a prospective study.

作者信息

Jiang Qianmei, Jing Jing, Hao Zhu, Gao Yan, Liu Tao, Yang Xinjian, Lv Ming, Chen Shuo, Zhang Zhe, Liu Xinyao, Yang Xiaomeng, Jiang Sili, Wang Zhaobin, Liu Lian

机构信息

Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

Tiantan Neuroimaging Center of Excellence, China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

出版信息

Eur Radiol. 2024 Dec 20. doi: 10.1007/s00330-024-11310-5.

DOI:10.1007/s00330-024-11310-5
PMID:39706920
Abstract

OBJECTIVES

To evaluate the prevalence and predictors of ischemic lesions on thin-slice DWI (2 mm) in endovascular treatments for unruptured intracranial aneurysms (UIA), particularly explore the potential relationship with pathway plaques.

METHODS

Participants eligible for endovascular treatments with UIA at a national stroke center between March 2023 and August 2023 were prospectively enrolled. All participants performed thin-slice DWI (slice thickness of 2 mm) before and after procedures. Three-dimensional joint intra-and extracranial vessel wall MRI (3D-vwMRI, voxel size 0.6 × 0.6 × 0.6 mm) was scheduled to evaluate the pathway plaques for all participants. The DWI-positive numbers were ordered and divided into four equal parts, with each quartile representing 25% of the data set.

RESULTS

A total of 106 participants were included. Overall, none of the participants exhibited preoperative DWI-positive lesions. Following the intervention, 93.4% (99/106) of participants exhibited new DWI-positive lesions on postoperative MRI, including 5.7% (6/106) with symptomatic ischemic stroke. Compared with the lowest quartile of ischemic lesions, the highest quartile was associated with increased odds of the presence of plaque (OR = 9.4, 95% CI: 2.0-45.4; p = 0.005). The history of previous stroke (OR = 4.6, 95% CI: 1.6-14.6; p = 0.007) and the presence of plaque in the pathway (OR = 3.4, 95% CI: 1.6-7.7; p = 0.002) were identified as independent predictors of higher quartiles of DWI-positive numbers.

CONCLUSIONS

As revealed by thin-slice DWI, ischemic lesions related to the endovascular treatments for UIA occurred more frequently than anticipated. A history of the previous stroke and the pathway plaques were independent predictors of higher quartiles of DWI-positive numbers.

KEY POINTS

Question Previous studies using conventional MRI may underestimate DWI-positive lesions. The procedural risk of UIA coexisting with atherosclerotic plaques is still unclear. Findings Thin-slice DWI showed ischemic lesions occurred frequently (93.4%). Three-dimensional-intra-and extracranial Vessel Wall MRI revealed a positive correlation between pathway plaques and DWI lesions. Clinical relevance Neuro-interventionalists should exercise caution when managing patients with a history of previous stroke in the presence of plaques in the treatment pathway. More vigilant pre-procedural imaging should be considered to assess unstable plaque in high-risk patients.

摘要

目的

评估未破裂颅内动脉瘤(UIA)血管内治疗中薄层扩散加权成像(DWI,层厚2mm)上缺血性病变的发生率及预测因素,尤其探讨其与路径斑块的潜在关系。

方法

前瞻性纳入2023年3月至2023年8月在某国家级卒中中心符合UIA血管内治疗条件的参与者。所有参与者在手术前后均进行薄层DWI(层厚2mm)检查。为所有参与者安排三维颅内和颅外血管壁磁共振成像(3D-vwMRI,体素大小0.6×0.6×0.6mm)以评估路径斑块。将DWI阳性数排序并分为四等份,每个四分位数代表数据集的25%。

结果

共纳入106名参与者。总体而言,所有参与者术前均未出现DWI阳性病变。干预后,93.4%(99/106)的参与者术后MRI出现新的DWI阳性病变,其中5.7%(6/106)发生有症状的缺血性卒中。与缺血性病变最低四分位数相比,最高四分位数与斑块存在几率增加相关(OR = 9.4,95%CI:2.0 - 45.4;p = 0.005)。既往卒中史(OR = 4.6,95%CI:1.6 - 14.6;p = 0.007)和路径中存在斑块(OR = 3.4,95%CI:1.6 - 7.7;p = 0.002)被确定为DWI阳性数较高四分位数的独立预测因素。

结论

薄层DWI显示,UIA血管内治疗相关的缺血性病变发生率高于预期。既往卒中史和路径斑块是DWI阳性数较高四分位数的独立预测因素。

关键点

问题 以往使用传统MRI的研究可能低估了DWI阳性病变。UIA与动脉粥样硬化斑块共存的手术风险仍不明确。发现 薄层DWI显示缺血性病变频繁发生(93.4%)。三维颅内和颅外血管壁MRI显示路径斑块与DWI病变之间呈正相关。临床意义 神经介入医生在治疗路径存在斑块的情况下,处理有既往卒中史的患者时应谨慎。应考虑更严格的术前成像以评估高危患者的不稳定斑块。

相似文献

1
Pathway plaques and diffusion-weighted lesion analysis after endovascular treatment of unruptured intracranial aneurysms: a prospective study.未破裂颅内动脉瘤血管内治疗后的通路斑块与弥散加权病变分析:一项前瞻性研究
Eur Radiol. 2024 Dec 20. doi: 10.1007/s00330-024-11310-5.
2
Early diffusion-weighted MRI lesions after treatment of unruptured intracranial aneurysms: a prospective study.治疗未破裂颅内动脉瘤后早期弥散加权 MRI 病灶:一项前瞻性研究。
J Neurosurg. 2017 Apr;126(4):1070-1078. doi: 10.3171/2016.2.JNS152456. Epub 2016 May 20.
3
Evaluation of ischemic lesion prevalence after endovascular treatment of intracranial aneurysms, as documented by 3-T diffusion-weighted imaging: a 2-year, single-center cohort study.3T 弥散加权成像评估颅内动脉瘤血管内治疗后缺血性病变的发生率:一项为期 2 年的单中心队列研究。
J Neurosurg. 2018 Apr;128(4):982-991. doi: 10.3171/2016.11.JNS161020. Epub 2017 Jun 9.
4
Factors Associated with Postprocedural Diffusion-Weighted Imaging-Positive Lesions in Endovascular Treatment for Unruptured Cerebral Aneurysms.与未破裂脑动脉瘤血管内治疗后扩散加权成像阳性病变相关的因素。
World Neurosurg. 2019 Oct;130:e457-e462. doi: 10.1016/j.wneu.2019.06.114. Epub 2019 Jun 24.
5
Microembolism after endovascular coiling of unruptured cerebral aneurysms: incidence and risk factors.未破裂脑动脉瘤血管内栓塞术后的微栓塞:发生率及危险因素
J Neurosurg. 2016 Mar;124(3):777-83. doi: 10.3171/2015.3.JNS142835. Epub 2015 Sep 18.
6
Diffusion weighted image documented cerebral ischemia in the postprocedural period following pipeline embolization device with shield technology treatment of unruptured intracranial aneurysms: a prospective, single center study.采用 Pipeline 栓塞装置密网支架技术治疗未破裂颅内动脉瘤后,扩散加权成像记录到的术后脑缺血:一项前瞻性、单中心研究。
J Neurointerv Surg. 2020 Apr;12(4):407-411. doi: 10.1136/neurintsurg-2019-015363. Epub 2019 Sep 26.
7
Difference in imaging biomarkers between transient and permanent neurological deficits after endovascular treatment of cerebrovascular aneurysms.血管内治疗脑血管动脉瘤后短暂性和永久性神经功能缺损的影像学标志物差异。
J Neurosurg. 2020 Jun 19;134(6):1861-1870. doi: 10.3171/2020.4.JNS192718. Print 2021 Jun 1.
8
Diffusion-Weighted Imaging-Detected Ischemic Lesions following Endovascular Treatment of Cerebral Aneurysms: A Systematic Review and Meta-Analysis.脑动脉瘤血管内治疗后扩散加权成像检测到的缺血性病变:一项系统评价和荟萃分析。
AJNR Am J Neuroradiol. 2017 Feb;38(2):304-309. doi: 10.3174/ajnr.A4989. Epub 2016 Nov 17.
9
Diffusion-weighted imaging-detected ischemic lesions associated with flow-diverting stents in intracranial aneurysms: safety, potential mechanisms, clinical outcome, and concerns.颅内动脉瘤血流导向支架置入术后扩散加权成像检测到的缺血性病变:安全性、潜在机制、临床结局及相关问题
J Neurosurg. 2015 Mar;122(3):627-36. doi: 10.3171/2014.10.JNS132566. Epub 2015 Jan 6.
10
Development and Validation of a Fusion Model Based on Carotid Plaques and White Matter Lesion Burden Imaging Characteristics to Evaluate Ischemic Stroke Severity in Symptomatic Patients.基于颈动脉斑块和白质病变负荷影像特征的融合模型用于评估有症状患者缺血性卒中严重程度的开发与验证
J Magn Reson Imaging. 2025 Feb;61(2):648-660. doi: 10.1002/jmri.29439. Epub 2024 May 13.

引用本文的文献

1
Artificial intelligence and MRI in sinonasal tumors discrimination: where do we stand?人工智能与磁共振成像在鼻窦肿瘤鉴别中的应用:我们目前的进展如何?
Eur Arch Otorhinolaryngol. 2025 Mar;282(3):1557-1566. doi: 10.1007/s00405-024-09169-9. Epub 2024 Dec 24.

本文引用的文献

1
DWI-Detected Ischemic Lesions after Endovascular Treatment for Cerebral Aneurysms: An Updated Systematic Review and Meta-analysis.磁共振弥散加权成像检测脑动脉瘤血管内治疗后缺血性病变:一项更新的系统评价和荟萃分析。
AJNR Am J Neuroradiol. 2023 Nov;44(11):1256-1261. doi: 10.3174/ajnr.A8024. Epub 2023 Oct 12.
2
Carotid Plaque-RADS: A Novel Stroke Risk Classification System.颈动脉斑块-RADS:一种新的卒中风险分类系统。
JACC Cardiovasc Imaging. 2024 Jan;17(1):62-75. doi: 10.1016/j.jcmg.2023.09.005. Epub 2023 Oct 11.
3
Prevalence and Procedural Risk of Intracranial Atherosclerotic Stenosis Coexisting With Unruptured Intracranial Aneurysm.
颅内未破裂动脉瘤合并颅内动脉粥样硬化狭窄的患病率和操作风险。
Stroke. 2023 Jun;54(6):1484-1493. doi: 10.1161/STROKEAHA.122.041553. Epub 2023 May 4.
4
New Diffusion Abnormalities Following Endovascular Treatment for Intracranial Atherosclerosis.颅内动脉粥样硬化血管内治疗后新的弥散异常。
Radiology. 2023 May;307(4):e221499. doi: 10.1148/radiol.221499. Epub 2023 Mar 28.
5
Characteristics of intracranial plaque in patients with non-cardioembolic stroke and intracranial large vessel occlusion.颅内大血管闭塞非心源性脑梗死患者颅内斑块的特征。
Stroke Vasc Neurol. 2023 Oct;8(5):387-398. doi: 10.1136/svn-2022-002071. Epub 2023 Mar 13.
6
Diffusion-weighted imaging lesions after endovascular treatment of cerebral aneurysms: A network meta-analysis.脑动脉瘤血管内治疗后的弥散加权成像病变:一项网状Meta分析。
Front Surg. 2023 Jan 16;9:964191. doi: 10.3389/fsurg.2022.964191. eCollection 2022.
7
Iatrogenic Diffusion-Weighted Imaging Lesions: What Is Their Impact and How Can It Be Measured?医源性弥散加权成像病变:它们的影响有多大,如何衡量?
Stroke. 2021 May;52(5):1929-1936. doi: 10.1161/STROKEAHA.120.033984. Epub 2021 Apr 8.
8
The Prophylactic Use of Tirofiban versus Oral Antiplatelet Medications in Stent-Assisted Coiling of Intracranial Aneurysms: A Meta-analysis.替罗非班与口服抗血小板药物在颅内动脉瘤支架辅助栓塞中的预防性应用:一项荟萃分析。
AJNR Am J Neuroradiol. 2021 Apr;42(4):713-719. doi: 10.3174/ajnr.A6996. Epub 2021 Mar 11.
9
Factors associated with the new appearance of cerebral microbleeds after endovascular treatment for unruptured intracranial aneurysms.与未破裂颅内动脉瘤血管内治疗后新出现脑微出血相关的因素。
Neuroradiology. 2021 Jul;63(7):1079-1085. doi: 10.1007/s00234-020-02616-4. Epub 2021 Jan 7.
10
Prophylactic administration of tirofiban for preventing thromboembolic events in flow diversion treatment of intracranial aneurysms.替罗非班预防颅内动脉瘤血流导向治疗中血栓栓塞事件的应用。
J Neurointerv Surg. 2021 Sep;13(9):835-840. doi: 10.1136/neurintsurg-2020-016878. Epub 2020 Nov 16.